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Background
Duffy antigen receptor for chemokines (DARC) binds
inflammatory chemokines including several that also
bind to CCR5. A recessive DARC allele which blocks
expression on red cells affects ~90% of sub-Saharan
Africans but very few people of non-African origin.
Approximately 50% of DARC null people show African
benign neutropenia. We have investigated whether
DARC acts as an HIV co-receptor and whether the null
phenotype affects risk of HIV infection.
Materials and methods
DARC was expressed in CD4+ cells to test if it acts as
an attachment or entry co-receptor for HIV-1 and HIV-
2. Genotyping of cohorts exposed to HIV-1 with respect
to DARC FyA, FyB and Fy null alleles was conducted to
assess its affect on neutropenia, CCL5 plasma levels and
relative risk of HIV-1 infection.
Results
HIV-2 strains but not HIV-1 strains utilised DARC as
an entry co-receptor. However, HIV-1 could bind to
DARC on red cells and be delivered to activated CD4+
T-cells resulting in subsequent infection. GWAS analysis
confirmed the link between DARC null genotype and
African benign neutropenia. The DARC null phenotype
with African benign neutropenia resulted in low CCL5
plasma levels and increased the relative risk of HIV-1
infection approximately 3-fold.
Conclusion
The African-specific DARC null allele increases risk of
HIV infection.
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